The temporal, PFGE and resistance pattern associations suggest that poultry products are only a minor source of human infections in Western Finland

被引:13
作者
Lyhs, Ulrike [1 ]
Katzav, Marianne [1 ]
Isohanni, Pauliina [1 ]
Heiska, Helmi [2 ]
Maijala, Riitta [2 ]
机构
[1] Univ Helsinki, Ruralia Inst, Seinajoki Unit, FI-60320 Seinajoki, Finland
[2] Finnish Food Safety Author Evira, FI-00790 Helsinki, Finland
关键词
Campylobacter; Poultry meat; Source attribution; Incidence; PFGE; Antimicrobial resistance; CAMPYLOBACTER-JEJUNI; COLI; CHICKEN; CONTAMINATION; SUSCEPTIBILITIES; SALMONELLA; QUINOLONE; STRAINS; WHOLE; MEAT;
D O I
10.1016/j.fm.2009.10.014
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In order to compare human and retail poultry meat thermophilic Campylobacter isolates originating in a regional area in Western Finland, minimum inhibitory concentration (MICs) for six antimicrobials (96 isolates) and pulsed-field gel electrophoresis (PFGE) (102 isolates) were analysed Campylobacter spp were detected in 10 5% Out of 305 fresh poultry products studied, 29 (90.5%) isolates were identified as Campylobacter jejum. Among the 70 human isolates, 66 (94.3%) isolates were identified as C jejuni. Only one C jejuni domestic poultry isolate showed resistance (ampicillin), whereas domestic human C jejuni isolates were more commonly resistant to ciprofloxacin, nalidixic acid, ampicillin and tetracycline The resistance in foreign human isolates was significantly more common than among domestic isolates. PFGE analysis with KpnI restriction enzyme resulted in 59 different PFGE types among the poultry and human isolates Three types were detected first in poultry meat and thereafter during the following month in domestic human samples, whereas the other conjoint types were detected only after many months This study Suggests that poultry products play only a minor role in human campylobacteriosis in the Study area and that the resistance found in domestic human isolates is not likely related to retail Poultry meat products. (C) 2009 Elsevier Ltd All rights reserved.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 37 条
[1]  
[Anonymous], 2009, FOOD SAFETY AUTHORIT
[2]   Broiler Campylobacter Contamination and Human Campylobacteriosis in Iceland [J].
Callicott, Kenneth A. ;
Haroardottir, Hjordis ;
Georgsson, Franklin ;
Reiersen, Jarle ;
Frioriksdottir, Vala ;
Gunnarsson, Eggert ;
Michel, Pascal ;
Bisaillon, Jean-Robert ;
Kristinsson, Karl G. ;
Briem, Haraldur ;
Hiett, Kelli L. ;
Needleman, David S. ;
Stern, Norman J. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2008, 74 (21) :6483-6494
[3]   Comparison of genetic profiles of Campylobacter strains isolated from poultry, pig and Campylobacter human infections in Brittany, France [J].
Denis, M. ;
Chidaine, B. ;
Laisney, M-J. ;
Kempf, I. ;
Rivoal, K. ;
Megraud, F. ;
Fravalo, P. .
PATHOLOGIE BIOLOGIE, 2009, 57 (01) :23-29
[4]   QUINOLONE RESISTANCE IN CAMPYLOBACTER ISOLATED FROM MAN AND POULTRY FOLLOWING THE INTRODUCTION OF FLUOROQUINOLONES IN VETERINARY-MEDICINE [J].
ENDTZ, HP ;
RUIJS, GJ ;
VANKLINGEREN, B ;
JANSEN, WH ;
VANDERREYDEN, T ;
MOUTON, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :199-208
[5]   Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].
Engberg, J ;
Aarestrup, FM ;
Taylor, DE ;
Gerner-Smidt, P ;
Nachamkin, I .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34
[6]  
*FINRES VET, 2005, FINN VET ANT RES MON, P1796
[7]   Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada [J].
Gaudreau, C ;
Gilbert, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2106-2108
[8]   A case-case comparison of Campylobacter coli and Campylobacter jejuni infection:: A tool for generating hypotheses [J].
Gillespie, IA ;
O'Brien, SJ ;
Frost, JA ;
Adak, GK ;
Horby, P ;
Swan, AV ;
Painter, MJ ;
Neal, KR .
EMERGING INFECTIOUS DISEASES, 2002, 8 (09) :937-942
[9]  
GINDONIS V, 2005, STANDARDIZED MOCULUM
[10]  
Hakanen A, 2003, EMERG INFECT DIS, V9, P267